Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.
Miyao K, Sawa M, Kurata M, Suzuki R, Sakemura R, Sakai T, Kato T, Sahashi S, Tsushita N, Ozawa Y, Tsuzuki M, Kohno A, Adachi T, Watanabe K, Ohbayashi K, Inagaki Y, Atsuta Y, Emi N. Miyao K, et al. Among authors: kohno a. Int J Hematol. 2017 Jan;105(1):79-86. doi: 10.1007/s12185-016-2095-y. Epub 2016 Sep 30. Int J Hematol. 2017. PMID: 27696283 Clinical Trial.
Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.
Terakura S, Onizuka M, Fukumoto M, Kuwatsuka Y, Kohno A, Ozawa Y, Miyamura K, Inagaki Y, Sawa M, Atsuta Y, Suzuki R, Naoe T, Morishita Y, Murata M; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: kohno a. Int J Hematol. 2020 Jan;111(1):84-92. doi: 10.1007/s12185-019-02741-8. Epub 2019 Sep 25. Int J Hematol. 2020. PMID: 31555969 Clinical Trial.
Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse.
Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Imahashi N, et al. Among authors: kohno a. Ann Hematol. 2015 Jul;94(7):1139-48. doi: 10.1007/s00277-015-2312-4. Epub 2015 Feb 15. Ann Hematol. 2015. PMID: 25680895
Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.
Mizuta S, Sawa M, Tsurumi H, Matsumoto K, Miyao K, Hara T, Takahashi T, Sakemura R, Kojima H, Kohno A, Oba MS, Morita S, Sakamoto J, Emi N. Mizuta S, et al. Among authors: kohno a. Int J Clin Oncol. 2018 Oct;23(5):980-988. doi: 10.1007/s10147-018-1300-9. Epub 2018 May 29. Int J Clin Oncol. 2018. PMID: 29845477 Free PMC article. Clinical Trial.
Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic Syndrome.
Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Kohno A, Onishi Y, Fukuhara N, Kasai M, Fujii N, Yokoyama H, Iida H, Kanemura N, Fujieda A, Ago H, Tsutsumi Y, Nakamura F, Yago K, Moriuchi Y, Ota S, Ohashi H, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: kohno a. Biol Blood Marrow Transplant. 2020 Jan;26(1):139-144. doi: 10.1016/j.bbmt.2019.09.021. Epub 2019 Sep 20. Biol Blood Marrow Transplant. 2020. PMID: 31546004 Free article. Clinical Trial.
Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.
Terakura S, Onizuka M, Fukumoto M, Kuwatsuka Y, Kohno A, Ozawa Y, Miyamura K, Inagaki Y, Sawa M, Atsuta Y, Suzuki R, Naoe T, Morishita Y, Murata M; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: kohno a. Int J Hematol. 2020 Jan;111(1):159-160. doi: 10.1007/s12185-019-02783-y. Int J Hematol. 2020. PMID: 31773494
Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy.
Kuwatsuka Y, Kohno A, Terakura S, Saito S, Shimada K, Yasuda T, Inamoto Y, Miyamura K, Sawa M, Murata M, Karasuno T, Taniguchi S, Nagafuji K, Atsuta Y, Suzuki R, Fukumoto M, Naoe T, Morishita Y; Nagoya Blood and Marrow Transplantation Group. Kuwatsuka Y, et al. Among authors: kohno a. Cancer Sci. 2012 Sep;103(9):1688-94. doi: 10.1111/j.1349-7006.2012.02342.x. Epub 2012 Jul 16. Cancer Sci. 2012. PMID: 22631696 Free PMC article. Clinical Trial.
BMI-1 is highly expressed in M0-subtype acute myeloid leukemia.
Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T, Seto M, Kohno A, Kitamura K, Itoh Y, Asou N, Hamajima N, Emi N, Naoe T. Sawa M, et al. Among authors: kohno a. Int J Hematol. 2005 Jul;82(1):42-7. doi: 10.1532/IJH97.05013. Int J Hematol. 2005. PMID: 16105758
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.
Konuma T, Kondo T, Yamashita T, Uchida N, Fukuda T, Ozawa Y, Ohashi K, Ogawa H, Kato C, Takahashi S, Kanamori H, Eto T, Nakaseko C, Kohno A, Ichinohe T, Atsuta Y, Takami A, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Konuma T, et al. Among authors: kohno a. Ann Hematol. 2017 Mar;96(3):469-478. doi: 10.1007/s00277-016-2909-2. Epub 2017 Jan 6. Ann Hematol. 2017. PMID: 28058493
229 results